Biotech
Biotech funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
Amplitude Fellowship Program 2026 — Historical Reference for the Paid Montreal Life Sciences Fellowship
Historical reference for the closed 2026 Amplitude Fellowship, a paid full-time Montreal venture-creation fellowship for late-stage life sciences PhD, MD, postdoc, or equivalent candidates.
BBSRC-STFC DeepTech Catalyst Bio 2026: Early-Stage BioTech Commercialisation Accelerator
UKRI’s BBSRC-STFC DeepTech Catalyst Bio (DTC Bio) is an open UK opportunity for young biotech start-ups with prior UKRI-linked support to secure up to £50,000 in R&D funding, an innovation voucher, and programme support to advance commercial-stage bioscience ideas.
Commercialize Deep Tech in Poland: NCBR STEP Grants for Hardware, Quantum, Robotics, Cleantech and Biotech Ventures
If your company is building a deep-tech product and can show a credible commercialization path, Poland’s STEP calls at NCBR fund industrial-scale R&D that is too expensive for an ordinary startup budget — prototype hardening, testing, certification, and pre-deployment validation. The 2026 Cleantech and Biotech windows are open now.
India BIRAC Biotechnology Ignition Grant
Historical reference for BIRAC's latest listed Biotechnology Ignition Grant call, which offered early-stage Indian biotech companies and LLPs up to INR 50 lakhs for an 18-month proof-of-concept project.
MassChallenge U.S. Early Stage Accelerator: Zero-Equity Support for Early-Stage Startups
MassChallenge program family for early-stage startups in finance, healthcare, climate, security and resiliency, and related challenge areas. The current fintech page says the U.S. Early Stage application will open soon; no current deadline is published.
NIH SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional): PAR-27-098
A late-stage small business commercialization bridge for U.S. NIH SBIR or STTR Phase II projects that need outsourced technical development, clinical studies, or market-readiness work before full commercialization.
NIH SBIR/STTR Omnibus Solicitation
NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) opportunities for early-stage biomedical commercialization.
NoFAR Life Sciences Bridging Program
Supports applied life-science and other academic R&D with a commercialization path toward Israeli industry through the Israel Innovation Authority Applied Research in Academia fund.
RFA-HL-26-017: NIH Catalyze Product Definition for Small Molecules and Biologics (R61/R33)
NIH's RFA-HL-26-017 supports early-stage translational projects that generate and validate therapeutic candidates for HLBS diseases through a phased R61/R33 development pathway.
Transfyr AI Fellowship 2026–2027: $125,000 Plus Benefits, GPUs, and Compute for One Year of Full-Time Machine Learning Research on How Science Is Actually Executed
Transfyr is funding a one-year, full-time research fellowship in Boston/Cambridge paying $125,000 plus benefits and compute for graduate students, recent PhDs, and postdocs who want to lead a frontier machine learning project on multimodal scientific-execution data.